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Other names: C2GnT-M; hC2GnT-M; C2GnT2; 
C2/C4gnT; GnT-M; mucus type C2GnT 
Location: 15q21.3 
Note: GCNT3/C2GnT-M is a single pass type II 
membrane protein belonging to glycosyltransferase 14 
family. 
DNA/RNA 
Note: Human GCNT3/C2GnT-M is located on 
chromosome 15 in the region of q21.3, oriented from 
centromere to telomere. 
Description 
Human GCNT3/C2GnT-M gene is approximatively 
8.26 kb in size and located in chromosome 15q21.3 at 
the position of 57,691,415 - 57,699,501. 
 
 
Schematic representation of Human GCNT3/C2GnT-M gene and transcripts. There are three different sized transcripts. (TIS, 
Transcription Initiation Site designated as +1; E, Exon; I, Intron; UTR, Untranslated region; ATG, start codon; ORF, Open reading 
frame). 
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Recently, the GCNT3/C2GnT-M promoter (-417/+187) 
containing two basal cis-regulatory region (-291/-182 
and -62/-43) was identified. The Th2 cytokine and 
retinoic acid responsive cis-regulatory elements reside 
in -417/+187 region. 
Transcription 
Human GCNT3/C2GnT-M contains three different 
sized transcripts: 2.3-2.5, 3.6-3.8 and 6.8-7.0 kb. The 
transcript 1 (approximatively 2.3-2.5kb) is made of 3 
exons, exon 1 (69-198 bp), exon 2 (333-401 bp), and 
exon 3 (1864 bp). Exon 3 contains 59 bp of 5' UTR, 
1314 bp of ORF and 491 bp of 3'UTR. It does not 
contain any introns. Whereas, the intermediate sized 
transcript (3.6-3.8kb) contains 1.3kb of intron 2 and the 
large sized transcript (6.8-7.0 kb) contains 4.5kb of 
intron 1 in addition to all three exons. Exon 1 is 
heterogeneous in size, which ranges from 69 to 198 bp 
depending on tissues and cells. Exon 1 is present in all
transcripts and has same 3' end but different 5' ends. A 
333 bp Exon 2 is identified in most of the mucus 
secreting tissues and airway epithelial cells while a 401 
bp of exon 2 is only detected in A549 cells. 
Protein 
Note: Human GCNT3/C2GnT-M (EC 2.4.1.102) has 
438 amino acids and molecular weight of 50,863 Da. 
 
 
The predicted GCNT3/C2GnT-M structure shows a short N-
terminal cytoplasmic tail (CT), a transmembrane domain (TM), 
a stem region and a long catalytic domain at the C-terminal 
region. 
Description 
GCNT3/C2GnT-M is a type II membrane protein 
located in the Golgi apparatus. It contains a nine-amino 
acid peptide tail at the N-terminus located in the 
cytoplasm, which is followed by a transmembrane 
domain consisted of 18 amino acids, a stem region, and 
a catalytic domain located in the Golgi lumen. The 
protein contains 13 cysteines, including 4 at the N-
terminal region, which are conserved among 
GCNT3/C2GnT-M across species, and 9 at the C-
terminal region, which are conserved among all mucin 
glycan b6GlcNAc branching enzymes. Structural 
information obtained from bovine GCNT3/C2GnT-M 
shows that among the 9 conserved cysteines, the 
second cysteine is unconjugated and the other 8 
cysteines form 4 cystine bonds between first and nith, 
third and seventh, fourth and fifth, and sixth and eighth. 
The disulfide bonds formed from the nine conserved 
cysteines are different between GCNT3/C2GnT-M and 
C2GnT-L. GCNT3/C2GnT-M contains two potential 
N-glycosyltaion sites at N-69 and N-289. 
Expression 
Human GCNT3/C2GnT-M gene is expressed in mucus-
secretory tissues in the following decreasing order of 
expression: Colon; testis; stomach; small intestine; 
adrenal gland; kidney; trachea; thyroid gland; Uterus; 
Ovary; Pancreas; fetal liver; Prostate. Unlike bovine 
GCNT3/C2GnT-M gene, the type of transcript 
expressed by hC2GnT-M gene is not tissue specific 
among the mucus secretory tissues. Expression of 
GCNT3/C2GnT-M gene is down regulated in colon 
and colorectal tumors and various colorectal cancer 
cells. GCNT3/C2GnT-M expression is regulated by 
various external agent(s). It is inhibited by EGF and 





GCNT3/C2GnT-M is responsible for the synthesis of 
all three branch structures, including core 2, core 4, and 
I antigen found in the glycans of secreted mucins. 
These three branch structures are generated by the 
transfer of GlcNAc from UDP-GlcNAc to core 1, core 
3, and I antigen, respectively as shown below. 
1. UDP-GlcNAc + Galbeta1-3GalNAca1-S/T gives 
Galbeta1-3(GlcNAcbeta1-6) GalNAca1-S/T + UDP. 
2. UDP-GlcNAc + GlcNAcbeta1-3GalNAc1a-S/T 
gives GlcNAcbeta1-3(GlcNAcbeta1-6) GalNAca1-S/T 
+ UDP. 
3. UDP-GlcNAc + GlcNAcbeta1-3Galbeta1-R gives 
GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-R + UDP(R: 
sugars). 
The primary function of secreted mucins is to protect 
mucus secretory epithelium by retention of water and
maintenance of the rheological properties of the mucus, 
and adherence to airborne and ingested pathogens to 
facilitate their removal from these tissues. The first two 
properties depend primarily on the carbohydrate 
content and this property depends on the heterogeneity 
of carbohydrate structure. Secreted mucins contain very 
high carbohydrate content, i.e. 70-90% by weight, and
very heterogeneous carbohydrate structure, e.g. up to 
100 different oligosaccharides in mucins isolated from 
a single donor. The three b6GlcNAc branch structures 
found in the secreted mucins are responsible for the 
increase of carbohydrate content and structural 
complexity. Decrease of GCNT3/C2GnT-M in the 
secretory epithelium can result in dehydration of the
mucus and compromise of bacterial clearance. 
Homology 
Human GCNT3/C2GnT-M shows a very high level of 
similarity to other non-human GCNT3/C2GnT-M: 
bovine (83%), rat (78%) and mouse (77%). Further, it 
shows moderate level of (48% and 38%) similarity to 
human C2GnT-L and C2GnT-T, respectively. 
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Implicated in 
Colorectal cancer 
Note: GCNT3/C2GnT-M enzyme is down regulated in 
colon and colorectal tumors and most cancerous cell 
derived from mucus-secretory tissues. Re-expression of 
GCNT3/C2GnT-M suppresses tumor growth in the 
xenografts of nude mice. 
Disease 
Colorectal cancer is the 3rd most common form of 
cancer and the 2nd leading cause of cancer-related 
death among men and women in the Western world. It 
causes 655,000 deaths worldwide per year. The 
survival rate of colorectal cancer is not much higher 
than 50% even if the disease is diagnosed at an early
stage. Colorectal cancer is mostly formed from 
adenomatous polyps. These polyps can be detected and 
removed during colonoscopy, which would decrease 
cancer death by greater than 80%. Metastasis of cancer 
cells through bowel wall of the colon to lymph nodes is 
very common. If metastasis is detected, 5 year survival 
rate is less than 10%. 
Prognosis 
Recent reports suggest that deficiency or down 
regulation of human GCNT3/C2GnT-M expression is 
associated with development of colitis and colorectal 
cancer. This enzyme may be used as a prognostic 
marker for colorectal cancer. 
Oncogenesis 
GCNT3/C2GnT-M expression is down regulated in 
colorectal cancers. Down regulation of 
GCNT3/C2GnT-M would lead to the production of 
secreted mucins with lower carbohydrate content and 
less heterogeneous carbohydrate, which would 
compromise the protective function of these mucins. As 
a result, bacteria can not be cleared effectively, which 
causes irritation of the epithelium and chronic 
inflammation, and eventually cancer. Its re-expression 
suppresses tumor cell spreading, adhesion, motility, 
and invasion. It also inhibits cell growth and colony-
forming ability, and induces apoptotic cell death.  
In addition, expression of C2GnT-M suppresses tumor 
growth in the xenografts of nude mice. The results 
suggest that GCNT3/C2GnT-M is important in 
protecting the normal functional architecture of colon 
epithelial cells. 
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